[1. Thompson, Sumner E., and A Eugene Washington. Epidemiology of sexually transmitted Chlamydia trachomatis infections. Epidemiologic reviews 5 (1983): 96.10.1093/oxfordjournals.epirev.a036266]Search in Google Scholar
[2. Walker, Jennifer, et al. Chlamydia trachomatis incidence and re-infection among young women–behavioural and microbiological characteristics. PloS one 7.5 (2012): e37778.10.1371/journal.pone.0037778]Search in Google Scholar
[3. Weinstock, Hillard, Stuart Berman, and Willard Cates. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspectives on sexual and reproductive health 36.1 (2004): 6-10.10.1363/3600604]Search in Google Scholar
[4. Stamm, Walter E. Chlamydia trachomatis infections: progress and problems. Journal of Infectious Diseases 179.Supplement 2 (1999): S380-S383.10.1086/513844]Search in Google Scholar
[5. Fenton, Kevin A., et al. Sexual behaviour in Britain: reported sexually transmitted infections and prevalent genital Chlamydia trachomatis infection. The Lancet 358.9296 (2001): 1851-1854.10.1016/S0140-6736(01)06886-6]Search in Google Scholar
[6. Morré, Servaas A., et al. The natural course of asymptomatic Chlamydia trachomatis infections: 45% clearance and no development of clinical PID after oneyear follow-up. International journal of STD & AIDS 13.suppl 1 (2002): 12-18.10.1258/095646202762226092]Open DOISearch in Google Scholar
[7. Cates, Willard, and Judith N. Wasserheit. Genital chlamydial infections: epidemiology and reproductive sequelae. American journal of obstetrics and gynecology 164.6 (1991): 1771-1781.10.1016/0002-9378(91)90559-A]Search in Google Scholar
[8. Satterwhite, Catherine Lindsey, et al. Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008. Sexually transmitted diseases 40.3 (2013): 187-193.10.1097/OLQ.0b013e318286bb5323403598]Search in Google Scholar
[9. de Figueirêdo, Camila Macêdo, et al. Analysis Of Scientific Production On Ophthalmia Case Study Of Newborn And Its Relationship With The Type Of Birth And Preventive Methods: Systematic Review And Meta-Analysis. International Archives of Medicine 9.1 (2016).]Search in Google Scholar
[10. Ferreira, Glenda Roberta Oliveira Naiff. Soroepidemiologia de Chlamydia trachomatis, Chlamydia pneumoniae e Treponema pallidum nas aldeias indígenas Bakajá, Apyterewa, Xingu e Mrotidjãm, Altamira, Pará, Brasil. (2010).]Search in Google Scholar
[11. Haggerty, Catherine L., et al. Risk of sequelae after Chlamydia trachomatis genital infection in women. Journal of Infectious diseases 201.Supplement 2 (2010): S134-S155.10.1086/65239520470050]Search in Google Scholar
[12. Jaschek, G., et al. Direct detection of Chlamydia trachomatis in urine specimens from symptomatic and asymptomatic men by using a rapid polymerase chain reaction assay. Journal of clinical microbiology 31.5 (1993): 1209-1212.10.1128/jcm.31.5.1209-1212.19932629058501220]Search in Google Scholar
[13. Morré, S. A., et al. Urogenital Chlamydia trachomatis serovars in men and women with a symptomatic or asymptomatic infection: an association with clinical manifestations?. Journal of Clinical Microbiology 38.6 (2000): 2292-2296.10.1128/JCM.38.6.2292-2296.2000]Search in Google Scholar
[14. Lee, Helen H., et al. Diagnosis of Chlamydia trachomatis genitourinary infection in women by ligase chain reaction assay of urine. The Lancet 345.8944 (1995): 213-216.10.1016/S0140-6736(95)90221-X]Search in Google Scholar
[15. Stephens, R. S., et al. Monoclonal antibodies to Chlamydia trachomatis: antibody specificities and antigen characterization. The Journal of Immunology 128.3 (1982): 1083-1089.10.4049/jimmunol.128.3.1083]Search in Google Scholar
[16. Ratti, Giulio. Chlamydia trachomatis antigens. U.S. Patent No. 8,114,401. 14 Feb. 2012.]Search in Google Scholar
[17. Chen, Ding, et al. Characterization of Pgp3, a Chlamydia trachomatis plasmid-encoded immunodominant antigen. Journal of bacteriology 192.22 (2010): 6017-6024.10.1128/JB.00847-10297643820851898]Search in Google Scholar
[18. Baud, D., L. Regan, and G. Greub. Comparison of five commercial serological tests for the detection of anti-Chlamydia trachomatis antibodies. European journal of clinical microbiology & infectious diseases 29.6 (2010): 669-675.10.1007/s10096-010-0912-420349260]Search in Google Scholar
[19. Stevens, Matthew P., et al. Development and evaluation of an ompA quantitative real-time PCR assay for Chlamydia trachomatis serovar determination. Journal of clinical microbiology 48.6 (2010): 2060-2065.10.1128/JCM.02308-09288450020392903]Search in Google Scholar
[20. Horner, Paddy J. Azithromycin antimicrobial resistance and genital Chlamydia trachomatis infection: duration of therapy may be the key to improving efficacy. Sexually transmitted infections 88.3 (2012): 154-156.10.1136/sextrans-2011-05038522416272]Search in Google Scholar
[21. Lanjouw, E., et al. 2010 European guideline for the management of Chlamydia trachomatis infections. International journal of STD & AIDS 21.11 (2010): 729-737.10.1258/ijsa.2010.01030221187352]Open DOISearch in Google Scholar
[22. Bhengraj, Apurb Rashmi, et al. Decreased susceptibility to azithromycin and doxycycline in clinical isolates of Chlamydia trachomatis obtained from recurrently infected female patients in India. Chemotherapy 56.5 (2010): 371-377.10.1159/00031499820938174]Open DOISearch in Google Scholar
[23. Pitsouni, Eleni, et al. Single-dose azithromycin versus erythromycin or amoxicillin for Chlamydia trachomatis infection during pregnancy: a meta-analysis of randomised controlled trials. International journal of antimicrobial agents 30.3 (2007): 213-221.10.1016/j.ijantimicag.2007.04.01517596917]Search in Google Scholar
[24. Hathorn, Emma, Catherine Opie, and Penny Goold. What is the appropriate treatment for the management of rectal Chlamydia trachomatis in men and women?. Sexually transmitted infections 88.5 (2012): 352-354.10.1136/sextrans-2011-05046622517887]Search in Google Scholar
[25. Thorpe, E. M., et al. Chlamydial cervicitis and urethritis: single dose treatment compared with doxycycline for seven days in community based practises. Genitourinary medicine 72.2 (1996): 93-97.10.1136/sti.72.2.9311956158698374]Search in Google Scholar
[26. Schwebke, J. R., et al. Re-evaluating the treatment of nongonococcal urethritis: emphasizing emerging pathogens–a randomized clinical trial. Clinical Infectious Diseases 52.2 (2011): 163-170.10.1093/cid/ciq074310625221288838]Open DOISearch in Google Scholar
[27. Kong, F. Y. S., et al. Azithromycin versus doxycycline for the treatment of genital chlamydia infection–a meta-analysis of randomised controlled trials. Clinical Infectious Diseases (2014): ciu220.10.1093/cid/ciu22024729507]Search in Google Scholar
[28. Kong, Fabian Yuh Shiong, and Jane Simone Hocking. Treatment challenges for urogenital and anorectal Chlamydia trachomatis. BMC infectious diseases 15.1 (2015): 1.10.1186/s12879-015-1030-9451851126220080]Search in Google Scholar
[29. Kissinger, Patricia J., et al. Azithromycin treatment failure for Chlamydia trachomatis among heterosexual men with nongonococcal urethritis. Sexually Transmitted Diseases 43.10 (2016): 599-602.10.1097/OLQ.0000000000000489503350727631353]Search in Google Scholar
[30. Lau, Chuen-Yen, and Azhar K. Qureshi. Azithromycin versus doxycycline for genital chlamydial infections: a meta-analysis of randomized clinical trials. Sexually transmitted diseases 29.9 (2002): 497-502.10.1097/00007435-200209000-0000112218839]Search in Google Scholar
[31. Rustomjee, Roxana, et al. A randomized controlled trial of azithromycin versus doxycycline/ciprofloxacin for the syndromic management of sexually transmitted infections in a resource-poor setting. Journal of Antimicrobial Chemotherapy 49.5 (2002): 875-878.10.1093/jac/dkf03412003988]Open DOISearch in Google Scholar
[32. Gambini, Daniele, et al. Mycoplasma genitaliumin Males With Nongonococcal Urethritis: Prevalence and Clinical Efficacy of Eradication. Sexually transmitted diseases 27.4 (2000): 226-229.10.1097/00007435-200004000-0000810782745]Search in Google Scholar
[33. Ibrahim Salah Eldin. Evaluation Of Azithromycin In Treatment Of Avulgaris. Diss. UOFK, 2015.]Search in Google Scholar
[34. Manhart, Lisa E., et al. Efficacy of antimicrobial therapy for Mycoplasma genitalium infections. Clinical Infectious Diseases 61.suppl 8 (2015): S802-S817.10.1093/cid/civ78526602619]Search in Google Scholar
[35. Perletti, Gianpaolo, et al. Antimicrobial therapy for chronic bacterial prostatitis. The Cochrane Library (2013).10.1002/14651858.CD009071.pub223934982]Search in Google Scholar
[36. Haddix, Anne C., Susan D. Hillis, and William J. Kassler. The cost effectiveness of azithromycin for Chlamydia trachomatis infections in women. Sexually Transmitted Diseases 22.5 (1995): 274-280.10.1097/00007435-199509000-000027502180]Open DOISearch in Google Scholar
[37. Genc, Mehmet, and Per-Anders Mardh. A cost-effectiveness analysis of screening and treatment for Chlamydia trachomatis infection in asymptomatic women. Annals of Internal Medicine 124.1_Part_1 (1996): 1-7.10.7326/0003-4819-124-1_Part_1-199601010-00001]Search in Google Scholar